1. Jia Y, et al. Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress. Am J Physiol Endocrinol Metab. 2018 Apr 1;314(4):E366-E376.

2. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Med J. 2006 Aust;185:424-427.

3. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Med J. Aust 2006;185:424-427. Perfalk E, Cunha-Bang SD, Holst KK, Keller S, Svarer C, Knudsen GM, Frokjaer VG. estosterone levels in healthy men correlate negatively with serotonin 4 receptor binding. Psychoneuroendocrinology. 2017 Jul;81:22-28.

4. Anupam B, et al. Association of total and calculated free testosterone with androgen deficiency symptoms in patients with type 2 diabetes. Int J Impot Res. 2019 Apr 18.

5. Grossmann M. Low testosterone in men with type 2 diabetes: significance andtreatment. J Clin Endocrinol Metab. 2011;96:2341-53.

6. Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33:1186-1192.

7. Keating NL, O’Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostatę cancer. J Clin Oncol. 2006;24:4448-4456.

8. Yabiku K, Nakamoto K, Tokushige A. Reintroducing testosterone in the db/db mouse partially restores normal glucose metabolism and insulin resistance in a leptin-independent manner. BMC Endocr Disord. 2018 Jun 13;18(1):38.

9. Fan W, et al. Functional potentiation of leptin-signal transducer and activator of transcription 3 signaling by the androgen receptor. Endocrinology. 2008 Dec;149(12):6028-36.

10. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770.

11. Cheng Q, Li YW, Yang CF, Zhong YJ, Li L. Ethanol-Induced Hepatic Insulin Resistance is Ameliorated by Methyl Ferulic Acid Through the PI3K/AKT Signaling Pathway. Front Pharmacol. 2019 Aug 29;10:949.

12. Ramachandran S, Hackett GI, Strange RC. Sex Hormone Binding Globulin: A Review of its Interactions With Testosterone and Age, and its Impact on Mortality in Men With Type 2 Diabetes. Sex Med Rev. 2019 Oct;7(4):669-678.

13. Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol. 2013;78: 321-9.

14. Pivonello R, Menafra D, Riccio E, et al. Metabolic Disorders and Male Hypogonadotropic Hypogonadism. Front Endocrinol (Lausanne). 2019;10:345. Published 2019 Jul 25.

15. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007 Apr;30(04):911-917.

16. Mathews L, Subramanya V, Zhao D, Ouyang P, Vaidya D, Guallar E, et al. Endogenous Sex Hormones and Endothelial Function in Postmenopausal Women and Men: The Multi-Ethnic Study of Atherosclerosis. J Womens Health (Larchmt). 2019 Jul;28(7):900-909.

17. Ong PJ, Patrizi G, Chong WC, Webb CM, Hayward CS, Collins P. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol. 2000;85:269-72.

18. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. AmHeart J. 1986;111:383-390.

19. Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Role of androgens in cardiovascular pathology. Vasc Health Risk Manag. 2018 Oct 15;14:283-290.

20. Peng Z, Shu B, Zhang Y, Wang M. Endothelial Response to Pathophysiological Stress. Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):e233-e243.

21. Cai J, Hong Y, Weng C, Tan C, Imperato-Mcginley J, Zhu Y-S. Androgen stimulates endothelial cell proliferation via an androgen receptor/ VEGF/cyclin A-mediated mechanism. Am J Physiol Heart Circ Physiol. 2011;300(4):H1210-H1221.

22. Campelo AE, Cutini PH, Massheimer VL, Christian HC, Rolls NJ, Morris JF. Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway. Nongenomic actions of testosterone on a subset of lactotrophs in the male rat pituitary. Endocrinology. 2000;141:3111-3119.

23. Wynne FL, Khalil RA. Testosterone and coronary vascular tone: Implications in coronary artery disease. J Endocrinol Invest. 2003;26(2):181-186.

24. Usselman CW, et al. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor. J Physiol. 2019 Jun;597(11):2853-2865.

25. Fernandez CJ, Chacko EC, Pappachan JM. Male Obesity-related Secondary Hypogonadism - Pathophysiology, Clinical Implications and Management. Eur Endocrinol. 2019 Aug;15(2):83-90.

26. Tajar A, Forti G, O’Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European male ageing study. J Clin Endocrinol Metab. 2010;95:1810-18.

27. Tsai EC, Boyko EJ, Leonetti DL, et al. Low serum testosterone level as a predictor of increased visceral fat in JapaneseAmerican men. Int J Obes Relat Metab Disord. 2000;24:485–91.

28. Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013 Apr 29;217(3):R25-45.

29. Cohen P. The hypogonadal–obesity cycle. Medical Hypotheses. 1999;52:49-51.

30. Schiffer L, Arlt W, O'Reilly MW. Understanding the Role of Androgen Action in Female Adipose Tissue. Front Horm Res. 2019;53:33-49.

31. Wells JC: Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007;21:415-430.

32. Pedersen SB, Fuglsig S, Sjogren P, Richelsen B. Identification of steroid receptors in human adipose tissue. Eur J Clin Invest 1996;26:1051-1056.

33. Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016;101:4178-4188.

34. Ek I, Arner P, Ryden M, Holm C, Thorne A, Hoffstedt J, Wahrenberg H. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 2002;51:484-492.

35. Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM. Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer. J Oncol Pract. 2018 Oct;14(10):580-587.

36. Faris JE, Smith MR. Metabolic sequelae associated with androgen deprivation therapy for prostate cancer. Curr Opin Endocrinol Diabetes Obes 201017:240-246.

37. Haider A1, Haider K1, Saad F2,3, Hanefeld M. Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report. SAGE Open Med Case Rep. 2019 Jan 16;7:2050313X18823454.

38. Jeelani H, Ganie MA, Masood A, Amin S, Kawa IA, Fatima Q. Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study. Diabetes Metab Syndr. 2019 Sep-Oct;13(5):2907-2915.

39. Adorni MP, Zimetti F, Cangiano B, Vezzoli V, Bernini F, Caruso D. High-Density Lipoprotein Function Is Reduced in Patients Affected by Genetic or Idiopathic Hypogonadism. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3097-3107.

40. KheraAV, DemlerOV, AdelmanSJ, CollinsHL, GlynnRJ, Ridker PM, Rader DJ, Mora S. Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER Trial (Justification for theUse of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Circulation. 2017;135(25):2494–2504.

41. Rubinow KB, Vaisar T, Chao JH, Heinecke JW, Page ST. Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men. J Clin Lipidol. 2018;12(4):1072-1082.

42. Asztalos BF, Horvath KV, Mehan M, Yokota Y, Schaefer EJ. Influence of HDL particles on cell-cholesterol efflux under various pathological conditions. J Lipid Res. 2017;58(6): 1238-1246.

43. Favari E, Calabresi L, Adorni MP, Jessup W, Simonelli S, Franceschini G, Bernini F. Small discoidal pre-beta1HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. Biochemistry. 2009;48(46):11067-11074.

44. Yassin A, Haider A, Haider KS, Caliber M, Doros G, Saad F, Garvey WT. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study. Diabetes Care. 2019 Jun;42(6):1104-1111.

45. Chen C, Zhai H, Huang G, Cheng J, Xia F, Zhao L. Is lower low-density lipoprotein cholesterol associated with lower androgen and erectile dysfunction in men? Nutr Metab Cardiovasc Dis. 2018 Dec;28(12):1304-1310.

46. Carr BR, Parker Jr CR, Ohashi M, MacDonald PC, Simpson ER. Regulation of human fetal testicular secretion of testosterone:low-density lipoprotein-cholesterol and cholesterol synthesized de novo as steroid precursor. Am J Obstet Gynecol. 1983;146:241e7.